Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of topical omiganan gel for prevention of catheter-site infection in central venous catheter patients
2005-003194-24Phase 3Completed
- Sponsor
- Cadence Pharmaceuticals, Inc.
- Start
- Nov 2005
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of omiganan in catheter infection and catheter colonization (2 arms), sponsored by Cadence Pharmaceuticals, Inc. Primary endpoint: Incidence of local catheter-site infection. Started Nov 2005; status: completed.
02
Drugs
omiganan
03
Conditions
catheter infectioncatheter colonization
Beyond the preview
Go deeper on 2005-003194-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003194-24.